L
Lapco Holdings Ltd
HKEX:8472
Lapco Holdings Ltd
HKEX:8472
Price:
0.375
HKD
Market Closed
Market Cap:
HK$43.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
L
|
Lapco Holdings Ltd
HKEX:8472
|
HK |
|
Geo Group Inc
NYSE:GEO
|
US |
|
Transgene Biotek Ltd
BSE:526139
|
IN |
|
Nibe Industrier AB
STO:NIBE B
|
SE |
|
K
|
Keskisuomalainen Oyj
OMXH:KSLAV
|
FI |
Balance Sheet
Balance Sheet Decomposition
Lapco Holdings Ltd
Lapco Holdings Ltd
Balance Sheet Decomposition is not available for
Lapco Holdings Ltd
Lapco Holdings Ltd
Balance Sheet
Lapco Holdings Ltd
Lapco Holdings Ltd
Currency: HKD
| Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||
| Cash & Cash Equivalents |
15
|
5
|
21
|
11
|
21
|
36
|
40
|
21
|
72
|
59
|
36
|
|
| Cash |
15
|
5
|
21
|
11
|
21
|
36
|
40
|
21
|
72
|
59
|
36
|
|
| Total Receivables |
98
|
84
|
146
|
157
|
156
|
121
|
133
|
178
|
140
|
84
|
109
|
|
| Accounts Receivables |
86
|
73
|
120
|
130
|
138
|
106
|
120
|
164
|
127
|
46
|
81
|
|
| Other Receivables |
12
|
12
|
26
|
27
|
18
|
15
|
14
|
14
|
13
|
38
|
28
|
|
| Other Current Assets |
9
|
9
|
9
|
22
|
22
|
43
|
22
|
30
|
30
|
18
|
18
|
|
| Total Current Assets |
123
|
98
|
177
|
190
|
199
|
200
|
196
|
229
|
242
|
161
|
163
|
|
| PP&E Net |
35
|
45
|
98
|
84
|
72
|
48
|
55
|
81
|
74
|
43
|
25
|
|
| PP&E Gross |
0
|
0
|
0
|
84
|
72
|
48
|
55
|
81
|
74
|
43
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
105
|
75
|
86
|
127
|
172
|
176
|
113
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
|
| Other Long-Term Assets |
5
|
9
|
19
|
6
|
6
|
6
|
0
|
13
|
14
|
3
|
6
|
|
| Total Assets |
163
N/A
|
152
-7%
|
293
+93%
|
280
-5%
|
277
-1%
|
254
-8%
|
251
-1%
|
322
+28%
|
330
+3%
|
207
-37%
|
197
-5%
|
|
| Liabilities | ||||||||||||
| Accounts Payable |
4
|
3
|
6
|
7
|
10
|
5
|
6
|
14
|
12
|
4
|
11
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
43
|
35
|
63
|
60
|
14
|
0
|
|
| Short-Term Debt |
70
|
49
|
99
|
110
|
0
|
0
|
0
|
20
|
0
|
1
|
0
|
|
| Current Portion of Long-Term Debt |
10
|
11
|
24
|
23
|
138
|
104
|
107
|
71
|
46
|
16
|
7
|
|
| Other Current Liabilities |
33
|
29
|
45
|
44
|
48
|
36
|
24
|
33
|
62
|
9
|
27
|
|
| Total Current Liabilities |
118
|
93
|
173
|
184
|
196
|
188
|
172
|
201
|
180
|
44
|
45
|
|
| Long-Term Debt |
15
|
19
|
53
|
44
|
38
|
9
|
13
|
22
|
22
|
12
|
5
|
|
| Deferred Income Tax |
3
|
4
|
3
|
1
|
0
|
0
|
1
|
1
|
5
|
3
|
1
|
|
| Other Liabilities |
2
|
2
|
2
|
1
|
8
|
4
|
7
|
19
|
22
|
3
|
3
|
|
| Total Liabilities |
137
N/A
|
117
-15%
|
231
+98%
|
230
-1%
|
241
+5%
|
201
-17%
|
192
-4%
|
243
+27%
|
229
-6%
|
61
-73%
|
54
-11%
|
|
| Equity | ||||||||||||
| Common Stock |
10
|
0
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
19
|
23
|
|
| Retained Earnings |
16
|
35
|
58
|
15
|
0
|
18
|
24
|
44
|
58
|
61
|
120
|
|
| Additional Paid In Capital |
0
|
0
|
0
|
31
|
31
|
31
|
31
|
31
|
38
|
66
|
0
|
|
| Total Equity |
26
N/A
|
35
+33%
|
62
+77%
|
50
-19%
|
35
-30%
|
54
+52%
|
59
+10%
|
79
+34%
|
101
+28%
|
146
+45%
|
143
-3%
|
|
| Total Liabilities & Equity |
163
N/A
|
152
-7%
|
293
+93%
|
280
-5%
|
277
-1%
|
254
-8%
|
251
-1%
|
322
+28%
|
330
+3%
|
207
-37%
|
197
-5%
|
|
| Shares Outstanding | ||||||||||||
| Common Shares Outstanding |
320
|
320
|
400
|
400
|
400
|
20
|
34
|
34
|
40
|
96
|
115
|
|
Switch to:
Switch to:
See Also
Discover More
